CUE short 2026-05-04 balance sheets Cue Biopharma
Cue Biopharma faces a deteriorating balance sheet, recurring operating losses, ATM dilution and PIPE-investor selling pressure.
NASDAQ
CUE
1 article
$128M Market cap · 2026-07-30
CUE short 2026-05-04 balance sheets Cue Biopharma faces a deteriorating balance sheet, recurring operating losses, ATM dilution and PIPE-investor selling pressure.